The spontaneous changes in left ventricular ejection fraction (LVEF) during the first 24 hours of a first transmural infarction were assessed in 34 patients by serial gated cardiac blood pool imaging. Major therapeutic interventions with a view to limit infarct size were not used. Four determinations of LVEF were performed. Study 1 was performed as soon as possible after admission to the hospital. Studies 2 and 3 were performed 2 and 4 hours, respectively, after study 1. Tlwenty-four patients (70%) had study I within 6 hours after the onset of acute chest pain and 10 had it 6-12 hours after the onset of chest pain. Study 4 was performed 24 hours after the onset of chest pain. Compared with study 1, 19 of 34 patients (56%) had spontaneous changes in LVEF in at least one of the subsequent studies, exceeding the expected variability in stable patients. The changes ranged from a 32% increase to 14% absolute decrease. LVEF improved in 11 patients and deteriorated in eight. These spontaneous changes in left ventricular performance indicate that a single assessment of LVEF during the early hours of transmural myocardial infarction may not properly characterize cardiac performance in an individual patient and may not be the most appropriate reference against which to compare subsequent evolution of left ventricular function. These data may have implications for studies of the effects of early therapeutic interventions on LVEF.
SUMMARY The spontaneous changes in left ventricular ejection fraction (LVEF) during the first 24 hours of a first transmural infarction were assessed in 34 patients by serial gated cardiac blood pool imaging. Major therapeutic interventions with a view to limit infarct size were not used. Four determinations of LVEF were performed. Study 1 was performed as soon as possible after admission to the hospital. Studies 2 and 3 were performed 2 and 4 hours, respectively, after study 1. Tlwenty-four patients (70%) had study I within 6 hours after the onset of acute chest pain and 10 had it 6-12 hours after the onset of chest pain. Study 4 was performed 24 hours after the onset of chest pain. Compared with study 1, 19 of 34 patients (56%) had spontaneous changes in LVEF in at least one of the subsequent studies, exceeding the expected variability in stable patients. The changes ranged from a 32% increase to 14% absolute decrease. LVEF improved in 11 patients and deteriorated in eight. These spontaneous changes in left ventricular performance indicate that a single assessment of LVEF during the early hours of transmural myocardial infarction may not properly characterize cardiac performance in an individual patient and may not be the most appropriate reference against which to compare subsequent evolution of left ventricular function. These data may have implications for studies of the effects of early therapeutic interventions on LVEF.
IN EXPERIMENTAL MODELS of infarction, ischemic myocardium can be salvaged by interventions that improve the balance between myocardial oxygen supply and demand. [1] [2] [3] [4] [5] [6] However, such clear-cut therapeutic benefit in human myocardial infarction has not been demonstrated.7 -3 One reason for this may be limitations in the techniques suitable for objective documentation of myocardial salvage in man. Recently, radionuclide techniques such as multigated cardiac blood pool imaging have been proposed for noninvasive assessment of global cardiac performance at the patient's bedside, thereby providing functional estimates of myocardial salvage. However, little is known about the spontaneous evolution of left ventricular (LV) performance during the early hours of acute infarction. It is during the first 6-12 hours that interventions probably will have their greatest therapeutic impact. In order for these measurements to be applied to this patient population, their variability during this period must be established. Thus, we performed serial assessment of LV ejection fraction (LVEF) using gated cardiac blood pool imaging during the first 24 hours of acute transmural myocardial infarction in a group of patients in whom major therapeutic interventions were not used. Our Thirty-four patients with their first transmural acute myocardial infarction were studied. Their mean age was 63 years (range 36-86 years). All had a typical history of myocardial infarction, and all demonstrated classic evolutionary electrocardiographic and serumcreatine kinase changes as defined by standard criteria.' In all instances, the first of the serial multigated equilibrium cardiac blood pool studies was performed at the bedside within 12 hours after the onset of chest pain. The patients entered in this study do not represent a consecutive series, but rather those who could be studied within the logistic constraints of our coronary care unit imaging program early enough in the course of the infarct. Patients with cardiogenic shock were excluded, as were patients with antecedent valvular or myocardial disease. Fifteen patients had a history of hypertension, but only eight were receiving antihypertensive medication at the time of admission (diuretics alone in four patients and diuretics in combination with a second drug in four). Two patients had a history of stable angina pectoris preceding the infarct, and both were treated with propranolol (maximal dose, 20 mg four times daily) and nitrates. Two patients were receiving procainamide for ventricular ectopy before admission. In all patients, preadmission medications were not continued. Before entering the study, written, informed consent was obtained in all patients.
Twenty-five patients had inferior wall myocardial infarction and nine had anterior wall infarction. This distribution approximates the anatomic distribution of acute myocardial infarction seen in our coronary care unit during the same period. Thirteen of the patients with inferior wall infarction had > I mm of ST-segment depression in the precordial leads. This finding is of potential prognostic significance.'
The standard infarct treatment regimen instituted in the coronary care unit was applied to all patients and consisted of morphine sulphate or mepiridine for relief of pain; prophylactic i.v. lidocaine (3 mg/min, after two appropriately spaced initial bolus injections); diazepam for sedation; heparin, 5000 U subcutaneously; oxygen by face mask or nasal cannula; and bedrest. No patient received any medication to limit infarct size, specifically, ,3-adrenergic blockers, slow-channel calcium antagonists, nitrates, or afterload reducers.
Imaging Protocol
All patients underwent bedside serial multigated equilibrium cardiac blood pool imaging studies. Study 1 was performed as soon as possible after arrival in the coronary care unit. Twenty-four (70%) of the 34 patients had the first multigated cardiac blood pool study performed within 6 hours (range 3-6 hours) after the onset of acute chest pain. In 10 patients, the study was performed 6-12 hours after the onset of chest pain. The mean (-+SD) time after onset of chest pain for the first study was 6 ± 2 hours. There was no difference in the timing of study 1 after onset of chest pain in patients with inferior or anterior wall infarction (6 ± 3 vs 5 + 2 hours, NS).
To assess LV ejection fraction (LVEF), study 1 was performed in the left anterior oblique position using a 10°caudal tilt; the obliquity chosen provided the best delineation of the septum. Studies 2 and 3 were performed 2 hours and 4 hours, respectively, after the first study. Study 4 was performed the next day, approximately 24 hours after the onset of acute infarction. At the time of each study, the patient's clinical status (Killip class'6) was assessed and heart rate and blood pressure were recorded.
Multigated Equilibrium Cardiac Blood Pool Imaging
A mobile computerized scintillation camera (DY-NAMO, Picker Corp, interfaced with a MUGACART Medical Data Systems) was used in 14 patients and a Sigma 420 camera interfaced with VIP 550 (Technicare) was used il 20 patients for bedside multigated equilibrium cardiac blood pool imaging. All studies in a given patient were obtained only with one system. For all studies, in vivo labeling of the patient's own red blood cells with technetium 99m-pertechnetate (25-30 mCi) was used according to standard techniques. 17 The energy window (20%) of the gamma camera was set symmetrically around the 140-keV photopeak. The scintillation data were acquired in gated frame mode using the R wave of the ECG as the synchronizing impulse and stored in computer core memory (64 x 64-word mode). The cardiac cycle was divided in 20-28 equal frames (each less than 40 msec in duration). A total of 175,000-250,000 counts/frame were accumulated in the whole field of view, resulting in 6000-20,000 counts in the left ventricle at end-diastole.
Assessment of LVEF
The processing of studies was performed using commercially available software. A variable region of interest was used. The edge of the left ventricle was defined as second derivative points on the count profile in each of the 28 frames using the MUGE program (Medical Data Systems). Using the QMICA program (Technicare), a varying region of interest was determined by changing the count threshold in four quadrants of the left ventricle so that these regions of interest by visual inspection accurately followed the outline of the contracting left ventricle throughout the cardiac cycle. LVEF was determined using background-corrected counts derived with varying regions of interest: (end-diastolic countsend-systolic counts)/end-diastolic counts.
Definition of Significant Change in LVEF
Studies from this laboratory have documented the intrinsic variability of LVEF using the techniques of the present study in stable patients."8 The mean variability of LVEF was significantly larger (p < 0.01) in patients with a normal LVEF (D 55%) than in those with an abnormal LVEF, when studies were performed twice on the same day and on different days. In 97% of the patients with abnormal LVEF, the variability was 5% (absolute) or smaller. However, 50% of the patients with normal LVEF exceeded this degree of variability and in 97% of the normal patients a variability as large as 12% occurred. This differential variability should be considered. Therefore, changes in LVEF greater than 5% in abnormal patients and greater than 12% in normal patients are significant changes.
Reproducibility and Quality Control
Previous studies from this laboratory established the inter-and intraobserver variability of computer assessment of LVEF. Using the two computer softwares, mean intraobserver variability was comparable (1.4 ± 1.2% for MUGE and 2.0 ± 1.3% for QMICA, NS). The variability was not different for normal or abnormal LVEFs.'8 All 131 multigated equilibrium cardiac blood pool studies in the present investigation were reprocessed four times by one of us without knowledge of clinical data or sequence of studies. The LVEF values in the present study represent the mean of these four determinations. To exclude unintentional bias in processing, random studies were reprocessed after several weeks and compared with previously noted values. The variations (range 0-6%, mean 2.5 ± 1.7%) that occurred were within the previously assessed intraobserver variability. I
Statistical Analysis
Data are presented as the mean + SD. Changes in LVEF and variabilities are expressed as absolute values of ejection fraction units; e.g., LVEF changing from 42% to 50% is an 8% change. An LVEF of 55% or more was considered normal. Since the variability of LVEF is dependent on baseline LVEF,'8 the results in patients with abnormal LVEF in study 1 
Results

Clinical Course
At the time of study 1, 26 patients were in Killip class 1, six in class 1I and two in class III. Of the 34 study patients, two died shortly after study 3, within the first 24 hours. One patient died of cardiac rupture, the other of progressive pump failure. Of the surviving patients, one developed rupture of the ventricular septum between study 3 and 4 and underwent surgical repair 2 Analysis of the data from individual patients revealed substantial spontaneous changes in LVEF over the 24-hour period. In the serial studies. both increases and decreases in LVEF were noted frequently. Compared with study 1, these changes ranged from a 32% absolute increase to 14% absolute decrease. The mean interstudy variation of LVEF was not related to the timing of the study during the 24-hour study period. The mean interstudy variability of LVEF in patients with acute myocardial infarction and initial abnormal LVEF (K 55%) was 5 + 5% for studies performed on the first day (study 1 compared with studies 2 and 3), and was 9 ± 8% for studies performed on different days (study I compared with study 4). Both mean variabilities are significantly greater (p < 0.02) than those observed in a comparable group of stable patients. '5 In contrast, the mean interstudy variability of LVEF in patients with acute myocardial infarction and initial normal LVEF was 6 + 5% for studies on the first day and 6 ± 4% for studies on different days. Neither value is significantly different from the mean variability observed in a comparable stable group of patients. I Figure 1 displays the spontaneous changes in LVEF Of the seven patients with an LVEF ¢ 55% at the initial study, three had a change in LVEF of > 12%; in two patients LVEF decreased; in one patient it4 improved; and in four patients LVEF did not change significantly. One of the seven patients with a normal LVEF at study 1 had an abnormal LVEF at study 4. Thus, of 34 patients with acute transmural myocardial infarction, LVEF changed significantly in 19 patients (56%): 11 patients improved and eight deteriorated. Analysis of variance of the serial studies in the overall group of 34 patients did not reveal a systematic change in LVEF during the 24-hour study period. The same was true when the patients were separated according to the location of infarction (table 1) .
Changes in LVEF and Clinical Variables
In order to analyze whether the 11 patients who demonstrated improvement of LVEF (group A) could be distinguished from the eight patients who demonstrated deterioration of LVEF (group B), these two Troups of patients were compared (tables 2A and 2B1). At the time of study I. the patients in group A had significantly lower mean LVEFs than the patients in (group B. 37 ± 13% vs 48 ± 12% (p < 0.05). At the time of study 1, six of I1 patients in group A and seven of eight patients in group B were Killip class I (NS).
At the tine of studv 1. the mean heart rate was significantly higher in group A than in group B, 90 + 21 vs 69 + 16 beats/min (p < 0.05). The mean blood pressure was not different between the two groups, 101 + 21 mmHgvs95 + 11 mmHg(NS).Themean rate-pressure product at the time of study I was significantly higher in group A than in group B, 92 ± 31 x 10 vs 65 ± 13 x 10' (p < 0.05). At the time of study 4, the mean rate-pressure product in group A had decreased significantly from the original value. to 75 + 19 x 10(' (p < 0.01). Although the mean heart rate did not change significantly, mean blood pressure decreased in group A, to 88 ± 6 nmm Hg (p < 0.05). By analysis of variance. there was no signiffihant difterence between studies in anv variable. Abbreviations: Ant = anterior wall infarct: BP = mean blood pressure; HR = mcean healrt rate; Int infarct: LVEF = left ventricular election traction: RPP = mean rate-pressure product, compared with studv 1. The shaded cones indicate the anticipated variability in either direction ofLVEF observed previously in 97% of stable patients without acute infarction.'5 In patients with abnormal LVEF (< 55%) changes >5% (absolute), anid in patients with normal LVEF (D 55%) changes > 12% (absolute) are considered significant and nonrandom changes. Sixteen of the patients with abniormal LVEF and three with normal LVEF had significant changes in LVEF compared wvith study I during the first 24 hours of acute invocardial infarction. of study 4, the mean rate-pressure products in groups A and B were not different.
In individual patients, there was no correlation between either direction or magnitude of changes in heart rate (r = -0.08), mean blood pressure (r = -0.09) or rate-pressure product (r -0. 17) and changes of LVEF (tables 2A and B ). There was no significant difference in peak serum enzyme levels or the distribution of infarct location between groups A and B. The incidence of precordial ST-segment depression in patients with inferior wall infarcts was not different in the two groups (four of nine patients in group A and three of five in group B).
Discussion
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Improved LV function also could be the result of resolving ischemia. Salvagable myocardium is present in experimental models up to 6 hours after infarc- Our study focused on serial assessment of global LVEF. Complete analysis of regional wall motion would require serial multiple view studies.3' This was performed in only 17 of 34 patients, too few for comprehensive analysis. Deterioration of regional wall motion, which may represent infarct expansion, was noted in only two patients; whereas regional wall motion improved in eight patients and remained unchanged in seven. 32 Pantridge et al. 33 and Mueller et al.34 observed transiently increased sympathetic stimulation, reflected in tachycardia and/or hypertension, in one-third of their patients early after their infarct. This may be not only secondary to pain and anxiety, but may occur as a consequence of neurogenic reflexes arising from the infarcted and adjacent myocardium. Such sympathetic stimulation also could result in an improved performance during the earliest measurements, predominantly through improved function in noninfarcted zones. Over time, as sympathetic stimulation decreases, LV function also may decrease, resulting in an apparent deterioration in performance.
Changes in LV function in patients with acute myocardial infarction have been reported. [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] Most studies have compared hemodynamic values obtained during the first days of the infarct to those obtained at later follow-up. These studies generally have indicated that improvement in cardiac performance may occur gradually in the majority of the surviving patients. In contrast, recent studies involving serial radionuclide assessment of LVEF during the subacute phase of infarction in stable patients have shown only minimal variation of LVEF.47'9 Thus far, no study has focused on LV function during the first 24 hours of infarction, which is the time frame within which most acute therapeutic interventions should be used. Although in the present study significant changes in LVEF occurred in individual patients, consistent with previous stud-ies,4749 mean LVEF for the overall group did not change (table 1) .
Our results also may have relevance with regard to the use of LVEF as suggested by Shah et al. 15 50 These investigators reported that a LVEF of 30% or less obtained during the first 24 hours of acute infarction was of prognostic value in predicting a high risk of hospital morbidity and mortality from pump failure. In the present study, four patients (nos 5, 11, 25 and 29) had LVEFs lower than 30% at the time of study 1. In three of these patients, LVEF had improved at the time of study 4 to greater than 30%. Therefore, for this specific application, it may be better to measure LVEF after the first 24 hours of infarction, when major changes are less likely to occur.
In conclusion, a single assessment of LVEF during the first 24 hours of acute myocardial infarction may not characterize LV performance properly in an individual patient. Dynamic and apparently unpredictable changes in LV function during the early hours of infarction hinder the validity of evaluating the effects of therapeutic interventions by comparing posttherapy data to a single baseline value.
